Cascara Ventures
VC Fund
Brussels, Belgium
Cascara Ventures is a VC fund in Brussels focused on Health Care and Biotechnology. Cascara Ventures is the new investment fund of Adriaan Hart de Ruijter, experienced entrepreneur and investor in life sciences. Founded in 2016, Cascara invests in the seed stage of companies that apply technology to prevention, therapy and research. Examples are vaccines, medical devices, pharmaceuticals, imaging, software, medical data, robotics, healthcare services, diagnostics and cell therapy.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Cascara Ventures invests in
Stages Cascara Ventures invests in
Countries Cascara Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $2M–$7.9M
Investment Focus
Industry
- Health Care 5 (38%)
- Biotechnology 5 (38%)
- Medical Device 5 (38%)
- Medical 4 (31%)
- Wearables 2 (15%)
Stage
- Series A 6 (46%)
- Seed 3 (23%)
- Series B 2 (15%)
- Series C 1 (8%)
- Venture - Series Unknown 1 (8%)
Country
- Germany 6 (46%)
- Finland 2 (15%)
- The Netherlands 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Adriaan Hart de Ruijter
Managing Director
|
Managing Director | Total investments: 10 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa). | $7.9M / Series A / May 27, 2025 | ||
| ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise hascreated the base for the Trammpolin design and the development towards a prototype. | $2.1M / Venture - Series Unknown / Dec 14, 2021 | ||
| Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa). | $1.2M / Seed / Oct 25, 2017 | ||
| ATRO Medical is a spin-out from DSM and Radboudumc and builds on the knowledge developed in the Public-Private Collaboration BioMedical Materials that started in 2010 with a consortium of universities, private companies, and financial support from the Dutch government. The collaboration between the clinical, biomechanical, and polymer expertise hascreated the base for the Trammpolin design and the development towards a prototype. | Series A / Jul 17, 2017 | ||
| Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. They have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivityreaction, they have made discoveries that allow for improved design of vaccines against common types of allergies. Their goal is to provide long-term relief for patients suffering from allergic symptoms, as well as reduce the social and economic burden allergies cause to both individuals and society. | $2M / Series A / Jan 23, 2017 | ||
| microDimensions produces innovative software solutions for the processing, analysis, and visualization of biomedical imagery, in particular on a cellular level. Employees of microDimensions continuously strive to create efficient algorithms fulfilling highest quality standards. A particular focus of the company is to offer software products thatcan be integrated into the existing customer workflow seamlessly. | Series A / Jun 16, 2016 | ||
| xbird is a provider of software solutions in the healthcare sector, founded in Berlin in 2015. The company uses artificial intelligence to personalize therapies for better results. Especially in diabetes therapy, the algorithms developed by xbird can record the behavior and lifestyle of patients using smartphones and other wearables. In this way,as part of holistic care, health risks can be identified and prevented and long-term treatment can be optimized. | Seed / Jan 01, 2016 | ||
| Preventicus engineers products for smartphones and smartwatches that obtain health parameters without any extra accessories. It generates data conclusive to a degree previously only obtainable by physicians. Preventicus’ software applications are certified medical devices with an accuracy verified in clinical studies. Its primary product is a classI medical device. Preventicus is the creator of Preventicus Heartbeats, a smart screening solution that identifies atrial fibrillation for stroke prevention, based on technologies that are present in a standard smartphone or smartwatch.Preventicus was founded in 2014 by Thomas Hübner. It is based in Jena, Germany. | Series A / Jan 01, 2016 | ||
| Fiagon develops clinical navigation systems that reimagine image guidance by improving the function of electromagnetic navigation. Fiagon's systems use electromagnetic tracking matrix algorithms and flexible pointer technology that indicates the position of the instrument used in the CT or MRI image data, allowing physicians to get accurateplanning, improve patient outcomes, and implementation of the operation. | Series C / Dec 31, 2015 | ||
| microDimensions produces innovative software solutions for the processing, analysis, and visualization of biomedical imagery, in particular on a cellular level. Employees of microDimensions continuously strive to create efficient algorithms fulfilling highest quality standards. A particular focus of the company is to offer software products thatcan be integrated into the existing customer workflow seamlessly. | Seed / Feb 27, 2014 | ||
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Cascara Ventures invest in?
Cascara Ventures invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series A and Seed stage. Most of the 13 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Cascara Ventures invest in?
Cascara Ventures typically joins rounds of $2M–$7.9M at Series A. These are whole funding-round sizes, not Cascara Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Cascara Ventures took part in.
How do I contact Cascara Ventures?
Public channels for Cascara Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cascara Ventures?
The team at Cascara Ventures includes Adriaan Hart de Ruijter (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
